ERBB2 and neoplasm: For the Type 2 T-helper cells, the Her2 + tumor and the luminal subtypes were identified, and the most relevant process implicated were the ERBB2 signaling pathway and the Fibroblast Growth Factor Receptor (FGFR) signaling pathway located in chromosomes 8q, 11q, and 17q (Figure 5C).